Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.8800
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $3.89 million as of August 22, 2025. Its market cap has decreased by -21.98% in one year.
Market Cap
3.89M
Enterprise Value
6.54M
Revenue
45.45M
Ranking
n/a
PE Ratio
5.71
Stock Price
$0.88
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 3.89M, a decrease of -98.25%. That is a compound annual growth rate of -13.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 3.89M | -67.21% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | 12.69M | -33.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 632.06M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |